JOURNAL OF MOLECULAR GRAPHICS & MODELLING, published by Elsevier Science Inc, is a leading peer-reviewed journal dedicated to the fields of molecular graphics and modeling. With an ISSN of 1093-3263 and an E-ISSN of 1873-4243, this journal has established its relevance since its inception in 1997, and continues to thrive as it extends its scope into 2024. Acknowledged for its impact in the academic community, it holds a Q2 ranking in both Computer Graphics and Computer-Aided Design and Materials Chemistry, as well as a Q3 ranking in Physical and Theoretical Chemistry and Spectroscopy, reflecting its significance across multidisciplinary research domains. Notably, the journal ranks in the 73rd percentile for Computer Graphics and maintains competitive standings in Materials Science and Chemistry areas. Although it does not currently offer open access options, the journal is an essential resource for researchers, professionals, and students who are engaged in cutting-edge studies and applications in molecular graphics, computational methods, and material design. By facilitating a deeper understanding of molecular interactions through innovative graphical modeling, the journal contributes significantly to advancements in science and technology.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Records of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.

Chem-Bio Informatics Journal is a dedicated platform for the dissemination of innovative research in the intersecting realms of biochemistry and computational science. Published by the CHEM-BIO INFORMATICS SOC in Japan, this journal embraces the rapidly evolving field of chemoinformatics and bioinformatics, fostering scholarly communication among researchers, professionals, and students alike. With its ISSN: 1347-6297 and E-ISSN: 1347-0442, the journal continues to enrich the scientific community by offering insights into novel methodologies and applications that bridge chemistry and biology. Although currently positioned in the fourth quartile in the biochemistry category according to Scopus rankings, contributing to this journal provides an invaluable opportunity for authors to showcase impactful findings that could resonate within the field. The journal is particularly committed to supporting interdisciplinary research that addresses complex biological problems through computational modeling and data analysis. By publishing high-quality and peer-reviewed articles, Chem-Bio Informatics Journal aims to enhance the scientific discourse and is poised to become a pivotal resource for advancing the frontiers of biochemistry and molecular biology.

Current Research in Structural Biology, published by Elsevier, is a pioneering Open Access journal that has rapidly gained prominence since its inception in 2019. With a focus on advancing the understanding of molecular and structural biology, this journal provides a platform for researchers and professionals to publish groundbreaking findings that contribute to the field's ongoing development. With a commendable Q2 ranking in both Molecular Biology and Structural Biology categories for 2023, it serves as a vital resource for the community, ensuring accessibility to high-quality research. The journal is indexed in Scopus, showcasing its significant impact and relevance, particularly with a ranking of #26/49 in the Structural Biology discipline. Located in the heart of the Netherlands, Current Research in Structural Biology not only fosters academic discourse but also encourages collaborative research efforts in addressing critical biological questions. Whether you are a researcher, student, or industry professional, this journal is essential for staying abreast of the latest advancements and trends in structural biology.

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.

Structural Dynamics-US, published by AIP Publishing, stands as a premier journal within the fields of Condensed Matter Physics, Instrumentation, Radiation, and Spectroscopy. Established in 2014 and operating under an Open Access model, this journal facilitates a broad dissemination of groundbreaking research, enabling researchers and professionals worldwide to contribute to and engage with cutting-edge developments in structural dynamics. With a significant impact highlighted by its Q1 Quartile rankings across multiple categories, and impressive Scopus rankings—including a noteworthy 13th place in Radiation—Structural Dynamics-US provides a vital platform for scholarly communication and innovation in scientific inquiry. The journal's commitment to accessibility and excellence underscores its role as a critical resource for researchers, academics, and students eager to advance their understanding and application of structural dynamics in various scientific contexts.

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.

Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.

Interdisciplinary Sciences-Computational Life Sciences, published by SPRINGER HEIDELBERG, is a premier journal dedicated to advancing the field of life sciences through the lens of computational methods. With an ISSN of 1913-2751 and an E-ISSN of 1867-1462, this journal serves as a significant platform for researchers and professionals alike, fostering innovation and collaboration across various disciplines. As a testament to its impact, the journal holds a Q2 category status in Biochemistry, Genetics and Molecular Biology, Computer Science Applications, and Health Informatics, reflecting its influential contributions and rigorous peer-review process. The Scopus rankings demonstrate its esteemed placement within its fields, with notable percentiles that highlight its relevance and reach. While the journal operates under a traditional access model, its commitment to publishing high-quality research continues to stimulate important discussions and developments within the scientific community. Founded in 2009 and converging through 2024, Interdisciplinary Sciences-Computational Life Sciences remains an essential resource for the latest discoveries at the intersection of computation and life sciences, appealing to both seasoned researchers and enthusiastic students eager to contribute to this dynamic field.